Epigenetics alternation in lung fibrosis and lung cancer

Epigenetics alternation in lung fibrosis and lung cancer

Respiratory disease including interstitial lung diseases (ILDs) and lung cancer is a group of devastating diseases that linked with increased morbidity and healthcare burden. However, respiratory diseases cannot be fully explained by the alternation of genetic information. Genetic studies described...

Szczegółowa specyfikacja

Opis bibliograficzny
Główni autorzy:	Xueren Li, Chunjing Feng, Shouchun Peng
Format:	Artykuł
Język:	English
Wydane:	Frontiers Media S.A. 2022-11-01
Seria:	Frontiers in Cell and Developmental Biology
Hasła przedmiotowe:	epigenetics alternation DNA histone lung cancer fibrosis
Dostęp online:	https://www.frontiersin.org/articles/10.3389/fcell.2022.1060201/full

Podobne zapisy

Epigenetic Therapy in Lung Cancer
od: Stephen V Liu, i wsp.
Wydane: (2013-05-01)

Epigenetics as a versatile regulator of fibrosis
od: Yangdan Liu, i wsp.
Wydane: (2023-03-01)

Progress of Epigenetic Methylation in Lung Cancer Research
od: Shaowei ZHANG, i wsp.
Wydane: (2017-09-01)

Epigenetic mechanisms and their effects on cancer incidence and treatment: a review study
od: Reyhane Hoshyar, i wsp.
Wydane: (2015-07-01)

Epigenetic modification in liver fibrosis: Promising therapeutic direction with significant challenges ahead
od: Runping Liu, i wsp.
Wydane: (2024-03-01)

The Crosstalk Between Epigenetic Mechanisms and Alternative RNA Processing Regulation
od: Jian Zhang, i wsp.
Wydane: (2020-08-01)

From Bench to Bedside: Targeting Epigenetics for Cancer Therapy
od: Jin-xu Fang, i wsp.
Wydane: (2011-12-01)

Epigenetic features are significantly associated with alternative splicing
od: Zhou Yuanpeng, i wsp.
Wydane: (2012-03-01)

Mechanisms and technologies in cancer epigenetics
od: Zaki A. Sherif, i wsp.
Wydane: (2025-01-01)

Epigenetics in Liver Fibrosis: Could HDACs be a Therapeutic Target?
od: Alex Claveria-Cabello, i wsp.
Wydane: (2020-10-01)

The epigenetics of breast cancer – Opportunities for diagnostics, risk stratification and therapy
od: Rieke Schröder, i wsp.
Wydane: (2022-06-01)

Genome-wide DNA methylation profiling reveals novel epigenetic signatures in squamous cell lung cancer
od: Yuan-Xiang Shi, i wsp.
Wydane: (2017-11-01)

Natural Compounds as Epigenetic Modulators in Cancer
od: Michael Schnekenburger, i wsp.
Wydane: (2019-04-01)

CRC-EBD: Epigenetic Biomarker Database for Colorectal Cancer
od: Xingyun Liu, i wsp.
Wydane: (2020-10-01)

Role of Histone Modifications in Kidney Fibrosis
od: Shengyu Pan, i wsp.
Wydane: (2024-05-01)

Metformin: Sentinel of the Epigenetic Landscapes That Underlie Cell Fate and Identity
od: Javier A. Menendez
Wydane: (2020-05-01)

Epigenetic alterations in cancer
od: Suganya Ilango, i wsp.
Wydane: (2020-03-01)

Epigenetic Repression of Chloride Channel Accessory 2 Transcription in Cardiac Fibroblast: Implication in Cardiac Fibrosis
od: Tinghui Shao, i wsp.
Wydane: (2021-11-01)

Epigenetic regulation in cancer therapy: From mechanisms to clinical advances
od: Lei Tao, i wsp.
Wydane: (2024-03-01)

Advancement of epigenetics in stroke
od: Jianhua Peng, i wsp.
Wydane: (2022-10-01)

Epigenetic reprogramming in gastrointestinal cancer: biology and translational perspectives
od: Yingjie Wang, i wsp.
Wydane: (2024-09-01)

Epigenetics in Inflammatory Breast Cancer: Biological Features and Therapeutic Perspectives
od: Flavia Lima Costa Faldoni, i wsp.
Wydane: (2020-05-01)

Metabolic recoding of epigenetics in cancer
od: Yi-Ping Wang, i wsp.
Wydane: (2018-05-01)

Role and potential therapeutic value of histone methyltransferases in drug resistance mechanisms in lung cancer
od: Linxiang Zhang, i wsp.
Wydane: (2024-03-01)

DNA methylation in small cell lung cancer
od: Xianmin Zhu, i wsp.
Wydane: (2023-06-01)

Disruption of the expression and function of microRNAs in lung cancer as a result of epigenetic changes
od: Kousuke eWatanabe, i wsp.
Wydane: (2013-12-01)

Research progress and applications of epigenetic biomarkers in cancer
od: Jianjun Gao, i wsp.
Wydane: (2024-04-01)

Epigenetic Properties of Compounds Contained in Functional Foods Against Cancer
od: Giulia Casari, i wsp.
Wydane: (2024-12-01)

Reciprocal Regulation of Metabolic Reprogramming and Epigenetic Modifications in Cancer
od: Xilan Yu, i wsp.
Wydane: (2018-09-01)

Epigenetics in ovarian cancer: premise, properties, and perspectives
od: Qilian Yang, i wsp.
Wydane: (2018-07-01)

Epigenetic regulation in lung cancer
od: Shahin Ramazi, i wsp.
Wydane: (2023-12-01)

Epigenetic modulation of immunotherapy cofactors to enhance tumor response in lung cancer
od: Anuhya Kommalapati, i wsp.
Wydane: (2021-01-01)

Dietary Compounds as Epigenetic Modulating Agents in Cancer
od: Ángeles Carlos-Reyes, i wsp.
Wydane: (2019-03-01)

SAHA inhibits lung fibroblast activation by increasing p66Shc expression epigenetically
od: Yiheng Dong, i wsp.
Wydane: (2024-12-01)

Cavitating lung cancer with underlying lung fibrosis treated as case of post-COVID-19 lung fibrosis with invasive mucormycosis
od: Shital Patil, i wsp.
Wydane: (2022-01-01)

CANCER EPIGENETICS AND THE ROLE OF DIETARY ELEMENTS
od: Farah Abid, i wsp.
Wydane: (2019-09-01)

Histone Deacetylases and their Inhibitors in Cancer Epigenetics
od: Kelly N. Hassell
Wydane: (2019-11-01)

Epigenetic marvels: exploring the landscape of colorectal cancer treatment through cutting-edge epigenetic-based drug strategies
od: Azar Tahghighi, i wsp.
Wydane: (2025-02-01)

Epigenetic events in male common urogenital organs cancer
od: Abdelkareem A. Ahmed, i wsp.
Wydane: (2016-12-01)

Epigenetic therapy of cancer
od: Stankov Karmen M., i wsp.
Wydane: (2014-01-01)